Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Cited by (621)

Items 201–300 of 621

1. Translating bioactive peptides for COVID-19 therapy
   Khushwant Singh Bhullar, Steven J. Drews, Jianping Wu · 2020 · European Journal of Pharmacology
2. Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2
   Syed Muhammad Ali Shah, Tahir Rasheed, Komal Rızwan, Muhammad Bilal, Hafiz M.N. Iqbal, Nasır Rasool, Sebastian Ionut Toma, Luigi Geo Marceanu, Elena Bobescu · 2020 · Journal of Infection and Public Health
3. In Silico Analysis of High‐Risk Missense Variants in Human ACE2 Gene and Susceptibility to SARS‐CoV‐2 Infection
   Asmae Saih, Hanâ Baba, Meryem Bouqdayr, Hassan Ghazal, Salsabil Hamdi, Anass Kettani, Lahcen Wakrim · 2021 · BioMed Research International
4. Evidence Supports a Causal Model for Vitamin D in COVID-19 Outcomes
   Gareth Davies, Attila Garami, Joanna Byers · 2020 · medRxiv
5. Precaution and prevention of coronavirus disease 2019 infection in the eye
   Meng-Jou Chen, Kao-Jung Chang, Chih‐Chien Hsu, Pei-Yu Lin, Catherine Jui-Ling Liu · 2020 · Journal of the Chinese Medical Association
6. In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus
   Can Türk, Seyhan Türk, Elif Sena Temirci, Ümi̇t Yavuz Malkan, İbrahim C. Haznedaroğlu · 2020 · Journal of the Renin-Angiotensin-Aldosterone System
7. SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
   Ishita Gupta, Balsam R. Rizeq, Eyad Elkord, Semir Vranić, Ala‐Eddin Al Moustafa · 2020 · Cancers
8. Cancer Stem Cells in Head and Neck Metastatic Malignant Melanoma Express Components of the Renin-Angiotensin System
   Sam Duro Siljee, Tessa Pilkington, Helen Dian Brasch, Nicholas A. Bockett, Josie Patel, Erin Paterson, Paul Frank Davis, Swee Thong Tan · 2020 · Life
9. Continuous Remote Patient Monitoring Shows Early Cardiovascular Changes in COVID-19 Patients
   Arik Eisenkraft, ‪Yasmin Maor‬‏, Keren Constantini, Nir Goldstein, Dean Nachman, Ran Levy, Michael Halberthal, Netanel A. Horowitz, Ron Golan, Elli Rosenberg et al. · 2021 · Journal of Clinical Medicine
10. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations
    Giris Jacob, Anat Aharon, Benjamin Brenner · 2020 · Frontiers in Physiology
11. Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?
    Mohamed Rafiullah · 2020 · The American Journal of the Medical Sciences
12. Delineating clinical characteristics and comorbidities among 206 COVID-19 deceased patients in India: Emerging significance of renin angiotensin system derangement
    Jaseela Majeed, Puneeta Ajmera, Ramesh Kishorilal Goyal · 2020 · Diabetes Research and Clinical Practice
13. COVID-19 and Hematology—What Do We Know So Far?
    Harshwardhan Vinod Khandait, Garima Gandotra, Sonali Sachdeva, Courtney Kramer, Derek M. R. Nye, Reshma Reddy Golamari, Rohit Jain · 2020 · SN Comprehensive Clinical Medicine
14. COVID-19 in Patients with Diabetes: Clinical Course, Metabolic Status, Inflammation, and Coagulation Disorder
    Беликина Дарья Викторовна, E. S. Malysheva, Александр Владимирович Петров, Некрасова Татьяна Анатольевна, Е. С. Некаева, Alla E. Lavrova, Д. Г. Зарубина, Kurban Atduev, Д М Магомедова, Leonid Grigor'evich Strongin · 2020 · Современные технологии в медицине
15. Possible protective role of 17β-estradiol against COVID-19
    Nabab Khan · 2020
16. Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
    Hristo L. Svilenov, Julia Sacherl, A. Reiter, Lisa S. Wolff, Cho‐Chin Cheng, Marcel Stern, Vincent Grass, Martin Feuerherd, Frank‐Peter Wachs, Nicole Simonavicius et al. · 2021 · Antiviral Research
17. COVID-19-Induced Myocarditis: Pathophysiological Roles of ACE2 and Toll-like Receptors
    Patrizia Pannucci, Sophie R. Jefferson, Jonathan Hampshire, Samantha Louise Cooper, Stephen John Hill, Jeanette Woolard · 2023 · International Journal of Molecular Sciences
18. Down’s syndrome and COVID-19: risk or protection factor against infection? A molecular and genetic approach
    Marcos Altable, Juan Moisés de la Serna · 2020 · Neurological Sciences
19. Molecular docking of compounds from Clinacanthus nutans extract detected by GC-MS analysis with the SARS-CoV-2 main protease and ACE2 protein
    Noor Zafirah Ismail, Ismail Abiola Adebayo, Nur Nadhirah Mohamad Zain, Hasni Arsad · 2021 · Natural Product Research
20. The ameliorative effect of angiotensin 1-7 on experimentally induced-preeclampsia in rats: Targeting the role of peroxisome proliferator-activated receptors gamma expression & asymmetric dimethylarginine
    Mervat H. El‐Saka, Nermin M. Madi, Rowida Raafat Ibrahim, Ghada Mahmoud Alghazaly, Shereef L. Elshwaikh, Manal I. El-Bermawy · 2019 · Archives of Biochemistry and Biophysics
21. Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy
    Xiaoyan Zuo, Sixin Ren, He Zhang, Jianfei Tian, Ruinan Tian, Baoai Han, Hui Liu, Qian Dong, Zhiyong Wang, Yanfen Cui et al. · 2022 · Journal of Translational Medicine
22. Modulation of the miR-122/Sirt-6/ACE2 axis on experimentally-induced myocardial infarction
    Zeinab M. Abdel-Nasser, Mai A. Zaafan, Amr M. Abdelhamid · 2022 · Chemico-Biological Interactions
23. COVID-19’s immuno-pathology and cardiovascular diseases
    Entezar Mehrabi Nasab, Hassan Aghajani, Reza Hassanzadeh Makoui, Seyyed Shamsadin Athari · 2023 · Journal of Investigative Medicine
24. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of our Sight?
    Seyyed Mohammad Ghahestani, Javad Mahmoudi, Sakineh Hajebrahimi, Amir‐Babak Sioofy‐Khojine, Hanieh Salehi‐Pourmehr, Fatemeh Sadeghi‐Ghyassi, Hadi Mostafaei · 2020 · Iranian Journal of Allergy Asthma and Immunology
25. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19
    Shweta Sinha, Alka Sehgal, Rakesh Sehgal · 2020 · Drug Discoveries & Therapeutics
26. Cancer Stem Cells in Metastatic Head and Neck Cutaneous Squamous Cell Carcinoma Express Components of the Renin-Angiotensin System
    Sam Duro Siljee, Olivia Buchanan, Helen Dian Brasch, Nicholas A. Bockett, Josie Patel, Erin Paterson, Gordon Purdie, Paul Frank Davis, Tinte Itinteang, Swee Thong Tan · 2021 · Cells
27. Angiotensin 1–7 significantly reduces diabetes-induced leukocyte recruitment both in vivo and in vitro
    Fleur Bossi, Stella Bernardi, Daniele De Nardo, Alessandra Bramante, Riccardo Candido, Renzo Carretta, Fabio Fischetti I, Bruno Fabris · 2015 · Atherosclerosis
28. Cardiovascular Pathophysiology, Epidemiology, and Treatment Considerations of Coronavirus Disease 2019 (COVID-19): A Review
    Jeremy Y. Levett, Valeria Raparelli, Vartan Mardigyan, Mark Jeffrey Eisenberg · 2020 · CJC Open
29. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection
    Iris Louise N. Cabbab, Rafael Vincent M. Manalo · 2020 · Virus Research
30. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
    Tales Lyra de Oliveira, Igor Santana de Melo, Léia Cardoso-Sousa, Igor Andrade Santos, Mohamad Bassim El Zoghbi, Caroline Gusson Shimoura, Renata Pereira Georjutti, Olagide Wagner de Castro, Luíz Ricardo Goulart, Ana Carolina Gomes Jardim et al. · 2020 · Frontiers in Physiology
31. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
    Noha Mohamed Badae, Asmaa Samy El Naggar, Samiha Mahmoud El Sayed · 2019 · Canadian Journal of Physiology and Pharmacology
32. Cardiovascular impact of COVID-19: an array of presentations.
    Hira Maab, Faryal Mustafa, Syeda Javeria Shabbir · 2021 · PubMed Central
33. Quantum tunnelling in the context of SARS-CoV-2 infection
    Betony Adams, Ilya Sinayskiy, Rienk van Grondelle, Francesco Petruccione · 2022 · Scientific Reports
34. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox
    Shaghayegh Haghjooy Javanmard, Kiyan Heshmat‐Ghahdarijani, Golnaz Vaseghi · 2020 · Infection Control and Hospital Epidemiology
35. Interplay of COVID-19 and cardiovascular diseases in Africa: an observational snapshot
    Graham Chakafana, Daniel W. Mutithu, Julian Hoevelmann, Ntobeko Ntusi, Karen S Sliwa · 2020 · Clinical Research in Cardiology
36. Cardiovascular manifestations of COVID-19
    Hasan Altamimi, AbdulRehman Abid, Fahmi Othman, Ashfaq Ahmad Abdul Hamid Patel · 2020 · Heart Views
37. Emerging Molecular Prospective of SARS-CoV-2: Feasible Nanotechnology Based Detection and Inhibition
    Sushmita Patra, Rout George Kerry, Ganesh Kumar Maurya, Bijayananda Panigrahi, Swati Kumari, Jyoti Ranjan Rout · 2020 · Frontiers in Microbiology
38. Molecular Mechanisms of Proteins — Targets for SARS-CоV-2 (Review)
    Andrey V. Morgun, Vladimir V. Salmin, Elizaveta B. Boytsova, Olga L. Lopatina, Alla B. Salmina · 2020 · Современные технологии в медицине
39. Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition
    I‐Chen Chen, Jao‐Yu Lin, Yi‐Ching Liu, Chee‐Yin Chai, Jwu‐Lai Yeh, Jong‐Hau Hsu, Bin‐Nan Wu, Zen‐Kong Dai · 2021 · Frontiers in Medicine
40. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses
    Yingying Cao, Xintian Xu, Simo Kitanovski, Lina Song, Jun Wang, Pei Hao, Daniel E. Hoffmann · 2021 · Frontiers in Immunology
41. ACE2 and COVID-19: using Antihypertensive Medications and Pharmacogenetic Considerations
    Eric Michael Snyder, Bruce D. Johnson · 2020 · Pharmacogenomics
42. A transcription regulatory network within the ACE2 locus may promote a pro-viral environment for SARS-CoV-2 by modulating expression of host factors
    Tayaza Fadason, Sreemol Gokuladhas, Evgeniia Golovina, Daniel Ho, Sophie L. Farrow, Denis M. Nyaga, Hong Pan, Neerja Karnani, Conroy Wong, Antony A. Cooper et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
43. Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review
    Mohammad Azizur Rahman, Mohammad Saidur Rahman, Nurul Mostafa Bin Bashir, Rajib Mia, Abul Hossain, Shajib Kumar Saha, Akter Jahan Kakon, Nirod Chandra Sarker · 2021 · International journal of medicinal mushrooms
44. A Genomic Survey of Angiotensin-Converting Enzymes Provides Novel Insights into Their Molecular Evolution in Vertebrates
    Yunyun Lv, Yanping Li, Yunhai Yi, Lijun Zhang, Qiong Shi, Jian Yang · 2018 · Molecules
45. Effect of Prolonged Infusion of Alamandine on Cardiovascular Parameters and Cardiac ACE2 Expression in a Rat Model of Renovascular Hypertension
    Ava Soltani Hekmat, Nahid Zare, Ali Moravej, Mohammad Hassan Meshkibaf, Kazem Javanmardi · 2019 · Biological and Pharmaceutical Bulletin
46. Molecular chronicles of cytokine burst in patients with coronavirus disease 2019 (COVID-19) with cardiovascular diseases
    Finosh Gnanaprakasam Thankam, Devendra K. Agrawal · 2020 · Journal of Thoracic and Cardiovascular Surgery
47. The role of angiotensin-converting enzyme 2 in the pathogenesis of COVID-19: the villain or the hero?
    Josef Klhůfek · 2020 · Acta Clinica Belgica
48. Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach
    José María Lamas-Barreiro, Mario Alonso-Suárez, Julián Fernández-Martín, Jesus Angel Saavedra-Alonso · 2020 · Nefrología (English Edition)
49. Projected supportive effects of PycnogenolⓇ in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection
    Franziska Weichmann, Peter Jörg Rohdewald · 2020 · International Journal of Antimicrobial Agents
50. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19
    Jesús Zepeda-Cervantes, Daniel Martínez-Flores, J. O. Ramírez-Jarquín, Angeles C. Tecalco-Cruz, N. Alavez-Pérez, Luis Vaca, R. Sarmiento-Silva · 2022 · Viruses
51. COVID-19 and ACE -inhibitors and angiotensin receptor blockers-: The need to differentiate between early infection and acute lung injury
    José Manuel González-Rayas, Ana Lilia Rayas‐Gómez, José Juan García González, José Manuel González-Yáñez, José A Hernández-Hernández, Rosa C. López-Sánchez · 2020 · Revista Colombiana de Cardiología
52. La deficiencia de vitamina D es un factor de riesgo de mortalidad en pacientes con COVID-19
    Rocío Adriana Reyes Pérez, Ana Victoria Puente Nieto, Adriana Martínez-Cuazitl, Edgardo Alonso Montelongo-Mercado, Arturo Rodríguez Tort · 2020 · Revista de Sanidad Militar
53. COVID-19 and the heart: what we have learnt so far.
    Kunal Bikram Shaha, Dhiraj Narayan Manandhar, Jung Rae Cho, Ashok Adhikari, Man Bahadur K C · 2021 · PubMed Central
54. SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Giau Van Vo, Eva Bagyinszky, Yoon Soo Park, John Hulme, Seong Soo A. An · 2021 · Advances in experimental medicine and biology
55. C1q Complement/Tumor Necrosis Factor-Associated Proteins in Cardiovascular Disease and COVID-19
    Yaoli Xie, Zhijun Meng, Jia Gao, Caihong Liu, Jing Wang, Rui Guo, Jianli Zhao, Bernard Lopez, Theodore A. Christopher, Daniel Lee et al. · 2021 · Proteomes
56. Cardiovascular Outcomes in the Acute Phase of COVID-19
    Hiroki Nakano, Kazuki Shiina, Hirofumi Tomiyama · 2021 · International Journal of Molecular Sciences
57. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
    José R. Vargas-Rodríguez, Idalia Garza Veloz, Virginia Flores‐Morales, Jose Isaias Badillo-Almaraz, María del Refugio Rocha-Pizaña, José J. Valdés-Aguayo, Margarita L. Martínez‐Fierro · 2022 · Frontiers in Medicine
58. The Good, The Bad and The Ugly: A Mathematical Model Investigates the Differing Outcomes Among CoVID-19 Patients
    Sarthak Sahoo, Siddharth Jhunjhunwala, Mohit Kumar Jolly, Mohit Kumar Jolly · 2020 · Journal of the Indian Institute of Science
59. COVID-19: A Review on Molecular Basis, Pathogenic Mechanisms, Therapeutic Aspects and Future Projections
    Muneeb A. Faiq, Ashutosh Kumar, Himanshu Narayan Singh, Vikas Pareek, Rizwana Qadri, Khursheed Raza, Chiman Kumari, Ravi Kant Narayan, Pavan Kumar, Maheswari Kulandhasamy et al. · 2020 · Preprints.org
60. COVID-19 related mortality profile at a tertiary care centre: A descriptive study
    Sudhir Bhandari, Raman Sharma, Ajit Singh Shaktawat, Subrata Banerjee, Bhoopendra Patel, Amit Tak, Deepa Meena, Abhishek Agarwal, Vishal Anand Gupta, Shrikant Sharma et al. · 2020 · Scripta Medica
61. A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency
    Elizabeth M. Sajdel · 2021 · Frontiers in Pharmacology
62. Supresión de angiotensina II en la infección por el virus SARS-CoV-2: una propuesta terapéutica
    José María Lamas-Barreiro, Mario Alonso-Suárez, Jorge Julián Fernández-Martín, Jesus Angel Saavedra-Alonso · 2020 · Nefrología
63. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
    Paul MacDaragh Ryan, Noel M. Caplice · 2020 · Open Heart
64. Teachings from COVID‐19 and aging—An oxidative process
    Misha Zarbafian, Steven H. Dayan, Sabrina Guillen Fabi · 2020 · Journal of Cosmetic Dermatology
65. Covid 19 and its Cardiovascular Effects
    Amit Rastogi, Prabhat Tewari · 2020 · Annals of Cardiac Anaesthesia
66. Inhalation exposure to silver nanoparticles induces hepatic inflammation and oxidative stress, associated with altered renin‐angiotensin system signaling, in Wistar rats
    Subhayu Nayek, Amie K. Lund, Guido F. Verbeck · 2021 · Environmental Toxicology
67. Intrarenal Renin–Angiotensin System Involvement in the Pathogenesis of Chronic Progressive Nephropathy—Bridging the Informational Gap Between Disciplines
    Leslie Obert, Kendall S. Frazier · 2019 · Toxicologic Pathology
68. From ACE2 to COVID-19: A multiorgan endothelial disease
    Richard Albert Stein, Lauren M. Young · 2020 · International Journal of Infectious Diseases
69. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction
    I-Chen Chen, Jao‐Yu Lin, Yi‐Ching Liu, Chee‐Yin Chai, Jwu‐Lai Yeh, Jong‐Hau Hsu, Bin‐Nan Wu, Zen‐Kong Dai · 2020 · International Journal of Medical Sciences
70. Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma
    Sam Duro Siljee, Bridget Milne, Helen Dian Brasch, Nicholas A. Bockett, Josie Patel, Paul Frank Davis, Andrew Kennedy‐Smith, Tinte Itinteang, Swee Thong Tan · 2021 · Biomolecules
71. Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
    Dejan Marčetić, Miroslav Samaržija, Andrea Vukić Dugac, Jelena Knežević · 2021 · Genes
72. The Pathophysiology of Virulence of the COVID-19 Virus
    Joseph De Soto, Shazia Tabassum Hakim, Frederick Boyd · 2020 · Preprints.org
73. Update for Anaesthetists on Clinical Features of COVID-19 Patients and Relevant Management
    Benedikt Preckel, Marcus Josephus Schultz, Alexander P. J. Vlaar, Abraham Hendrikus Hulst, Jeroen Hermanides, Menno D. de Jong, Wolfgang S Schlack, Markus F. Stevens, Robert P. Weenink, Markus Werner Hollmann · 2020 · Journal of Clinical Medicine
74. Unveiling the Interplay—Vitamin D and ACE-2 Molecular Interactions in Mitigating Complications and Deaths from SARS-CoV-2
    Sunil J. Wimalawansa · 2024 · Biology
75. Review on COVID-19 Etiopathogenesis, Clinical Presentation and Treatment Available with Emphasis on ACE2
    Himani Rathi, Vishakha Burman, Sudip Kumar Datta, Satya Vati Rana, Anissa Atif Mirza, Sarama Saha, Raman Kumar, Manisha Naithani · 2021 · Indian Journal of Clinical Biochemistry
76. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges
    Al Hakim, Md. Mahbub Hasan, Mahmudul Hasan, Syed Mohammad Lokman, Kazi Faizul Azim, Topu Raihan, Parveen Afroz Chowdhury, Abul Kalam Azad · 2021 · Frontiers in Microbiology
77. Clinical characteristics and outcomes of COVID-19 patients with a history of cardiovascular disease
    Tofigh Yaghubi Kalurazi, Vahid Shakoori, Sara Nasiri, Mona Keivan, Chanour Tavakol, Shahin Ahanjide, Ali Alavi Foumani, Samaneh Mirzaei Dahka, Mohammad Sadegh Esmaeili Delshad, Niloofar Faraji · 2022 · Journal of Current Biomedical Reports
78. Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
    Leili Rahimi, Mojtaba Malek, Faramarz Ismail‐Beigi, Mohammad E. Khamseh · 2020 · Advances in Therapy
79. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads
    Martijn Hoevenaar, Dolf Goossens, Janne Roorda · 2020 · Journal of the Renin-Angiotensin-Aldosterone System
80. Hypotensive and Hepatoprotective Properties of the Polysaccharide-Stabilized Foaming Composition Containing Hydrolysate of Whey Proteins
    А.Г. Кручинин, Оlga S. Savinova, Olga A. Glazunova, Konstantin V. Moiseenko, Evgeniya Yu. Agarkova, Т. В. Федорова · 2021 · Nutrients
81. A novel angiotensin I-converting enzyme inhibitory peptide APPLRP from Grifola frondosa ameliorated the Ang II-induced vascular modeling in zebrafish model by mediating smooth muscle cells
    Tianyuan Song, Tiantian Zhang, Qiaolin Cai, Yin‐Yi Ding, Zhenyu Gu · 2024 · International Journal of Biological Macromolecules
82. Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression
    Jasmine Shirazi, Michael J. Donzanti, Katherine M. Nelson, Ryan Zurakowski, Catherine A. Fromen, Jason P. Gleghorn · 2020 · Cellular and Molecular Bioengineering
83. The effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on ischemic stroke and the possible underlying mechanisms
    Yuxia Song, Hongyang Fan, Xiaojia Tang, Yuhan Luo, Peipei Liu, Yingzhu Chen · 2021 · International Journal of Neuroscience
84. Rooibos, a supportive role to play during the COVID-19 pandemic?
    Naeem Sheik Abdul, Jeanine Lucasta Marnewick · 2021 · Journal of Functional Foods
85. Serum ACE2 Level is Associated With Severe SARS-CoV-2 Infection: A Cross-Sectional Observational Study
    Amjad Bani Hani, Nafez Abu Tarboush, Mo’ath Bani Ali, Fahad Alabhoul, Fahad Alansari, Ahmad A Abuhani, Mustafa Al-Kawak, Badea’a Shamoun, Suzan Albdour, Mahmoud A Abu Abeeleh et al. · 2022 · Biomarker Insights
86. Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents
    Naglaa F. Boraey, M. A. Bebars, Ali A. Wahba, Hanan M. Abd El-Lateef, Mohamed Attia, Ahmed H. Elsayed, K. Rashed, E. Sorour, Mohamed F. Ahmed, Ghada A. B. Abd-Elrehim et al. · 2024 · Pediatric Research
87. Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin–angiotensin system
    Seldağ Bekpınar, Ece Karaca, Selin Yamakoğlu, Ilkay Alp Yildirim, Vakur Olgaç, B. Sönmez Uydeş-Doğan, Ezgi Cibali, Suleyman Gultepe, Müjdat Uysal · 2019 · Canadian Journal of Physiology and Pharmacology
88. Features of electrocardiographic changes in non-coronarogenic syndromes in patients with COVID-19
    Evgeny V. Shlyakhto, Е. В. Пармон, Бернгардт Эдвард Робертович, Е. С. Жабина · 2020 · Russian Journal of Cardiology
89. Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic
    Luca Perico, Ariela Benigni, Giuseppe Remuzzi · 2020 · Current Opinion in Nephrology & Hypertension
90. Cardiovascular Impacts on COVID-19 Infected Patients
    Somasundaram Raghavan, R. Gayathri, Sudhakar Kancharla, Prachetha Kolli, J. Ranjitha, S. P. Vijayalakshmi · 2021 · Frontiers in Cardiovascular Medicine
91. Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs
    Mohamed A. Elrayess, Hadeel T. Zedan, Rand A. Alattar, Hatem Mabrouk Abusriwil, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, Jabeed Parengal, Bassem Al Hariri, Hadi Mohamad Yassine, Ali Ait Hssain et al. · 2022 · Blood Pressure
92. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation
    Ching Siang Tan, Siang Fei Yeoh, Chiau Ming Long · 2020 · Annals of the Academy of Medicine Singapore
93. Association between pulmonary function and rapid kidney function decline: a longitudinal cohort study from CHARLS
    Shisheng Han, Yanqiu Xu, Yi Wang · 2024 · BMJ Open Respiratory Research
94. Role of the RAAS in mediating the pathophysiology of COVID-19
    Jakub Jasiczek, Adrian Doroszko, Tymoteusz Trocha, Małgorzata Trocha · 2024 · Pharmacological Reports
95. COVID-19 AND CARDIOVASCULAR DISEASES
    Ya. V. Polonskaya, E. V. Kashtanova, E. M. Stakhneva, E. V. Sadowski, Yu. I. Ragino · 2020 · Ateroscleroz
96. Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
    Sarama Saha, Sasanka Chakrabarti, Praveen Kumar Singh, Jit Poddar, Soumitra Satapathi, Surendra Kumar Saini, Sham S. Kakar, Partha Roy · 2020 · Stem Cell Reviews and Reports
97. Severe acute respiratory syndrome coronavirus 2 and renin-angiotensin system blockers: A review and pooled analysis
    Mathieu Kernéis, Arnaud Ferrante, Paul Guedeney, Éric Vicaut, Gilles Montalescot · 2020 · Archives of cardiovascular diseases
98. Tropical Food Spices: A Promising Panacea for the Novel Coronavirus Disease (COVID‐19)
    Adedayo Oluwaseun Ademiluyi, Olubukola Helen Oyeniran, Ganiyu Oboh · 2020 · eFood
99. Computational Guided Approach for Drug Repurposing Against SARS-CoV-2
    Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai · 2021 · Future Virology
100. Association between Serum Angiotensin-converting Enzyme 2 Level with Postoperative Morbidity and Mortality after Major Pulmonary Resection in Non-small Cell Lung Cancer Patients
     Xiaobing Li, Changwei Zhou, Wen Hu · 2014 · Heart Lung and Circulation